Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

  1. Ochoa, M.C.
  2. Perez-Ruiz, E.
  3. Minute, L.
  4. Oñate, C.
  5. Perez, G.
  6. Rodriguez, I.
  7. Zabaleta, A.
  8. Alignani, D.
  9. Fernandez-Sendin, M.
  10. Lopez, A.
  11. Muntasell, A.
  12. Sanmamed, M.F.
  13. Paiva, B.
  14. Lopez-Botet, M.
  15. Berraondo, P.
  16. Melero, I.
Journal:
OncoImmunology

ISSN: 2162-402X 2162-4011

Year of publication: 2019

Volume: 8

Issue: 7

Type: Article

DOI: 10.1080/2162402X.2019.1599636 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals